Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company, 55493-55497 [2020-19805]
Download as PDF
<![CDATA[
55493
jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 85, No. 174 / Tuesday, September 8, 2020 / Notices
Act of 1930, as amended, 19 U.S.C.
1337, and in section 210.10 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.10 (2020).
Scope of Investigation: Having
considered the complaint, the U.S.
International Trade Commission, on
September 1, 2020, ordered that—
(1) Pursuant to subsection (b) of
section 337 of the Tariff Act of 1930, as
amended, an investigation be instituted
to determine whether there is a
violation of subsection (a)(1)(B) of
section 337 in the importation into the
United States, the sale for importation,
or the sale within the United States after
importation of certain products
identified in paragraph (2) by reason of
infringement of one or more of claims 1,
3, 6, 7, 12, 21–24, 29, 30, and 33–38 of
the ’985 patent and claim 1 of the ’705
patent; and whether an industry in the
United States exists as required by
subsection (a)(2) of section 337;
(2) Pursuant to section 210.10(b)(1) of
the Commission’s Rules of Practice and
Procedure, 19 CFR 210.10(b)(1), the
plain language description of the
accused products or category of accused
products, which defines the scope of the
investigation, is ‘‘variable speed wind
turbine generators having low and zero
voltage ride through capability and
components thereof, namely generators,
power converters, uninterruptible
power supplies, turbine controllers,
blade pitch control systems, and
converter controllers’’;
(3) For the purpose of the
investigation so instituted, the following
are hereby named as parties upon which
this notice of investigation shall be
served:
(a) The complainant is:
General Electric Company, 5 Necco
Street, Boston, MA 02210
(b) The respondents are the following
entities alleged to be in violation of
section 337, and are the parties upon
which the complaint is to be served:
Siemens Gamesa Renewable Energy
Inc., 3500 Quadrangle Boulevard,
Orlando, FL 32817
Siemens Gamesa Renewable Energy A/
S, Borupvej 16, 7330 Brande,
Denmark
Gamesa Electric, S.A.U., Parque
Tecnolo´gico de Bizkaia, Building 206,
48170 Zamudio, BI, Spain
(4) For the investigation so instituted,
the Chief Administrative Law Judge,
U.S. International Trade Commission,
shall designate the presiding
Administrative Law Judge.
The Office of Unfair Import
Investigations will not participate as a
party in this investigation.
VerDate Sep<11>2014
16:32 Sep 04, 2020
Jkt 250001
Responses to the complaint and the
notice of investigation must be
submitted by the named respondents in
accordance with section 210.13 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.13. Pursuant to
19 CFR 201.16(e) and 210.13(a), as
amended in 85 FR 15,798 (Mar. 19,
2020), such responses will be
considered by the Commission if
received not later than 20 days after the
date of service by the complainant of the
complaint and the notice of
investigation. Extensions of time for
submitting responses to the complaint
and the notice of investigation will not
be granted unless good cause therefor is
shown.
Failure of a respondent to file a timely
response to each allegation in the
complaint and in this notice may be
deemed to constitute a waiver of the
right to appear and contest the
allegations of the complaint and this
notice, and to authorize the
administrative law judge and the
Commission, without further notice to
the respondent, to find the facts to be as
alleged in the complaint and this notice
and to enter an initial determination
and a final determination containing
such findings, and may result in the
issuance of an exclusion order or a cease
and desist order or both directed against
the respondent.
By order of the Commission.
Issued: September 1, 2020.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2020–19747 Filed 9–4–20; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–710]
Importer of Controlled Substances
Application: Cambridge Isotope
Laboratories
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
may also file a written request for a
hearing on the application on or before
October 8, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on July 23, 2020,
Cambridge Isotope Laboratories, 50
Frontage Road, Andover, Massachusetts
01810, applied to be registered as an
importer of the following basic class(es)
of controlled substances:
Controlled substance
Gamma Hydroxybutyric
Acid.
Tetrahydrocannabinols ..
Morphine ........................
Drug
code
Schedule
2010
I
7370
9300
I
II
The company plans to import the
listed controlled substances for
analytical research, testing and clinical
trials. No other activity for these drug
codes is authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–19806 Filed 9–4–20; 8:45 am]
BILLING CODE 4410–09–P
Cambridge Isotope
Laboratories has applied to be registered
as an importer of basic class(es) of
controlled substances. Refer to
Supplemental Information listed below
for further drugs information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before October 8, 2020. Such persons
SUMMARY:
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–708]
Bulk Manufacturer of Controlled
Substances Application: Cayman
Chemical Company
Drug Enforcement
Administration, Justice.
AGENCY:
E:\FR\FM\08SEN1.SGM
08SEN1
55494
ACTION:
Federal Register / Vol. 85, No. 174 / Tuesday, September 8, 2020 / Notices
Notice of application.
Cayman Chemical Company
has applied to be registered as a bulk
manufacturer of basic class(es)
controlled substances. Refer to
Supplemental Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before November 9, 2020. Such
persons may also file a written request
SUMMARY:
for a hearing on the application on or
before November 9, 2020.
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
ADDRESSES:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
In
accordance with 21 CFR 1301.33(a), this
is notice that on July 17, 2020, Cayman
Chemical Company, 1180 East Ellsworth
Road, Ann Arbor, Michigan 48108–
2419, applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substances:
SUPPLEMENTARY INFORMATION:
Drug
code
jbell on DSKJLSW7X2PROD with NOTICES
Controlled substance
3-Fluoro-N-methylcathinone (3-FMC); 1-(3-Fluorophenyl)-2-(Methylamino)Propan-1-one) ........................................................
Cathinone .....................................................................................................................................................................................
Methcathinone .............................................................................................................................................................................
4-Fluoro-N-methylcathinone (4-FMC); Flephedrone; 1-( 4-Fluorophenyl)-2-(Methylamino)Propan-1-one) ................................
Pentedrone (a-methylaminovalerophenone), its optical, positional and geometric isomers, salts and salts of isomers ...........
Mephedrone (4-Methyl-N-methylcathinone) ................................................................................................................................
4-Methyl-N-ethylcathinone (4-MEC) ............................................................................................................................................
Naphyrone, its optical, positional and geometric isomers, salts and salts of isomers ...............................................................
N-Ethylamphetamine ...................................................................................................................................................................
N,N-Dimethylamphetamine ..........................................................................................................................................................
Fenethylline ..................................................................................................................................................................................
Aminorex ......................................................................................................................................................................................
4-Methylaminorex (cis isomer) ....................................................................................................................................................
Gamma Hydroxybutyric Acid .......................................................................................................................................................
Methaqualone ..............................................................................................................................................................................
Mecloqualone ...............................................................................................................................................................................
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ...............................................................................................................
SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) .............................................................
ADB-FUBINACA (n-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ..........................
5-Flouro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone .............................
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ..................................
FUB-144 .......................................................................................................................................................................................
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) ...................................................................................................................................
MDMB-FUBINACA (Methyl 2-(1–4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ....................................
2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3- methylbutanoate .......................................................................................
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ......................................................
THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone ................................................................................
5F-AB-PINACA ............................................................................................................................................................................
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide ..............................
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) .....................
5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazola-3-carboxamido)-3-methylbutanoate) ...........................................................
5F-ADB; 5F-MDMB-PINACA (Methyl 2-(1-(5fluoropentyl)-1H-indazole-3-carboxamido)-3,3dimethylbutanoate) .......................
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ..............................................
5F-EDMB-PINACA .......................................................................................................................................................................
5F-MDMB-PICA) ..........................................................................................................................................................................
MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1-(cyclohenxylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanote)- ......
MMB-CHMICA .............................................................................................................................................................................
FUB-AKB48;FUB-APINACA; AKB48 N-(4-Fluorobenzyl) ............................................................................................................
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide ...........................................................................
5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-1-(5fluoropentyl)-1H-indazole-3-carboxamide) .................................................
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ...............................................................................................................
5F-CUMYL-PINACA;SGT-25 .......................................................................................................................................................
5F-CUMYL-P7AICA .....................................................................................................................................................................
4-CN-CUMYL-BUTINACA ...........................................................................................................................................................
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole ..................................................................................
JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ...........................................................................................
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ..................................................................................................................
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ..............................................................................
JWH-073 (1-Butyl-3-(1-naphthoyl)indole) ....................................................................................................................................
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) .......................................................................................................
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ...................................................................................................................
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ...................................................................................................................
NM2201 .......................................................................................................................................................................................
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ..............................................................................................................
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ..........................................................................................
4-Methyl-Alpha-Ethylaminopentiophennone ................................................................................................................................
VerDate Sep<11>2014
16:32 Sep 04, 2020
Jkt 250001
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
E:\FR\FM\08SEN1.SGM
08SEN1
1233
1235
1237
1238
1246
1248
1249
1258
1475
1480
1503
1585
1590
2010
2565
2572
6250
7008
7010
7011
7012
7014
7019
7020
7021
7023
7024
7025
7031
7032
7033
7034
7035
7036
7041
7042
7044
7047
7048
7049
7081
7083
7085
7089
7104
7118
7122
7144
7173
7200
7201
7203
7221
7222
7225
7245
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
55495
Federal Register / Vol. 85, No. 174 / Tuesday, September 8, 2020 / Notices
Drug
code
jbell on DSKJLSW7X2PROD with NOTICES
Controlled substance
N-Ethylhexedrone, its optical, positional and geometric isomers, salts and salts of isomers ....................................................
Alpha-ethyltryptamine ..................................................................................................................................................................
Ibogaine .......................................................................................................................................................................................
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) .............................................................................
CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) .......................................................
Lysergic acid diethylamide ..........................................................................................................................................................
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) ............................................................................................................
Marihuana ....................................................................................................................................................................................
Tetrahydrocannabinols ................................................................................................................................................................
Mescaline .....................................................................................................................................................................................
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2 ) ........................................................................................................
3,4,5-Trimethoxyamphetamine ....................................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine ..........................................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ......................................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine ..........................................................................................................................................
2,5-Dimethoxyamphetamine ........................................................................................................................................................
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ...................................................................................................................
2,5-Dimethoxy-4-ethylamphetamine ............................................................................................................................................
3,4-Methylenedioxyamphetamine ................................................................................................................................................
5-Methoxy-3,4-methylenedioxyamphetamine ..............................................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine ..............................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine ...................................................................................................................................
3,4-Methylenedioxymethamphetamine ........................................................................................................................................
4-Methoxyamphetamine ..............................................................................................................................................................
5-Methoxy-N-N-dimethyltryptamine .............................................................................................................................................
Alpha-methyltryptamine ...............................................................................................................................................................
Bufotenine ....................................................................................................................................................................................
Diethyltryptamine .........................................................................................................................................................................
Dimethyltryptamine ......................................................................................................................................................................
Psilocybin .....................................................................................................................................................................................
Psilocyn ........................................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine ..........................................................................................................................................
4-CHLORO-ALPHA-Pyrrolidinovalerophenone, its optical, positional and geometric isomers, salts and salts of isomers .......
4-METHYL-ALPHA-Pyrrolidinohexiophenone, its optical, positional and geometric isomers, salts and salts of isomers .........
N-Ethyl-1-phenylcyclohexylamine ................................................................................................................................................
1-(1-Phenylcyclohexyl)pyrrolidine ................................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine ...........................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine ..........................................................................................................................................
N-Benzylpiperazine ......................................................................................................................................................................
4-Methyl-Alpha-pyrrolidinopropiophenone, its optical, positional and geometric isomers, salts and salts of isomers ...............
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D) ...............................................................................................................
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E ) .................................................................................................................
2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) ..............................................................................................................................
2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C-I) .....................................................................................................................
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C) ...............................................................................................................
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N) .................................................................................................................
2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P) ..........................................................................................................
2-[4-(Isopropylthio)-2,5-dimethoxyphenyl] ethanamine (2C-T-4 ) ...............................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) ...................................................................................................................................
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B-NBOMe) .................................................................
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe) ..................................................................
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I-NBOMe) ......................................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ..................................................................................................................
Butylone, its optical, positional and geometric isomers, salts and salts of isomers ...................................................................
Pentylone, its optical, positional and geometric isomers, salts and salts of isomers .................................................................
N-Ethylpentylone, or Ephylone ....................................................................................................................................................
ALPHA-Pyrrolidinohexanophenone .............................................................................................................................................
alpha-pyrrolidinopentiophenone (a-PVP), its optical, positional and geometric isomers, salts and salts of isomers ................
alpha-pyrrolidinobutiophenone (a-PBP), its optical, positional and geometric isomers, salts and salts of isomers ..................
Ethylone .......................................................................................................................................................................................
ALPHA-Pyrrolidinoheptaphenone, its optical, positional and geometric isomers, salts and salts of isomers ............................
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ................................................................................................................
Acetyldihydrocodeine ...................................................................................................................................................................
Benzylmorphine ...........................................................................................................................................................................
Codeine-N-oxide ..........................................................................................................................................................................
Desomorphine ..............................................................................................................................................................................
Etorphine (except HCl) ................................................................................................................................................................
Codeine methylbromide ...............................................................................................................................................................
Dihydromorphine ..........................................................................................................................................................................
Heroin ..........................................................................................................................................................................................
Morphine-N-oxide ........................................................................................................................................................................
Normorphine ................................................................................................................................................................................
U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ...........................................................................
VerDate Sep<11>2014
16:32 Sep 04, 2020
Jkt 250001
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
E:\FR\FM\08SEN1.SGM
08SEN1
7246
7249
7260
7297
7298
7315
7348
7360
7370
7381
7385
7390
7391
7392
7395
7396
7398
7399
7400
7401
7402
7404
7405
7411
7431
7432
7433
7434
7435
7437
7438
7439
7443
7446
7455
7458
7470
7473
7493
7498
7508
7509
7517
7518
7519
7521
7524
7532
7535
7536
7537
7538
7540
7541
7542
7543
7544
7545
7546
7547
7548
7694
9051
9052
9053
9055
9056
9070
9145
9200
9307
9313
9547
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
55496
Federal Register / Vol. 85, No. 174 / Tuesday, September 8, 2020 / Notices
Drug
code
jbell on DSKJLSW7X2PROD with NOTICES
Controlled substance
AH-7921 .......................................................................................................................................................................................
MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) ...............................................................................................................
Etonitazene ..................................................................................................................................................................................
Ketobemidone ..............................................................................................................................................................................
Tilidine ..........................................................................................................................................................................................
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) .............................................................................................
Para-Fluorofentanyl .....................................................................................................................................................................
3-Methylfentanyl ...........................................................................................................................................................................
Alpha-methylfentanyl ...................................................................................................................................................................
Acetyl-alpha-methylfentanyl .........................................................................................................................................................
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide ...................................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ...........................................................................................
Butyryl Fentanyl ...........................................................................................................................................................................
Para-fluorobutyryl fentanyl ...........................................................................................................................................................
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1phenethylpiperidin-4-yl)isobutyramide) ......................................................
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide .....................................................................................................
Para-chloroisobutyryl fentanyl .....................................................................................................................................................
Isobutyryl fentanyl ........................................................................................................................................................................
Beta-hydroxyfentanyl ...................................................................................................................................................................
Beta-hydroxy-3-methylfentanyl ....................................................................................................................................................
Alpha-methylthiofentanyl ..............................................................................................................................................................
3-Methylthiofentanyl .....................................................................................................................................................................
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) .........................................................................
Thiofentanyl .................................................................................................................................................................................
Beta-hydroxythiofentanyl .............................................................................................................................................................
Para-methoxybutyryl fentanyl ......................................................................................................................................................
Ocfentanil .....................................................................................................................................................................................
Valeryl fentanyl ............................................................................................................................................................................
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide ......................................................................................
Cyclopropyl Fentanyl ...................................................................................................................................................................
Cyclopentyl fentanyl .....................................................................................................................................................................
Fentanyl related-compounds as defined in 21 CFR 1308.11(h) .................................................................................................
Amphetamine ...............................................................................................................................................................................
Methamphetamine .......................................................................................................................................................................
Lisdexamfetamine ........................................................................................................................................................................
Phenmetrazine .............................................................................................................................................................................
Methylphenidate ...........................................................................................................................................................................
Amobarbital ..................................................................................................................................................................................
Pentobarbital ................................................................................................................................................................................
Secobarbital .................................................................................................................................................................................
Glutethimide .................................................................................................................................................................................
1-Phenylcyclohexylamine ............................................................................................................................................................
Phencyclidine ...............................................................................................................................................................................
4-Anilino-N-phenethyl-4-piperidine (ANPP) .................................................................................................................................
Norfentanyl ...................................................................................................................................................................................
Phenylacetone .............................................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile ............................................................................................................................................
Cocaine ........................................................................................................................................................................................
Codeine ........................................................................................................................................................................................
Etorphine HCl ..............................................................................................................................................................................
Dihydrocodeine ............................................................................................................................................................................
Oxycodone ...................................................................................................................................................................................
Hydromorphone ...........................................................................................................................................................................
Ecgonine ......................................................................................................................................................................................
Ethylmorphine ..............................................................................................................................................................................
Hydrocodone ................................................................................................................................................................................
Levomethorphan ..........................................................................................................................................................................
Levorphanol .................................................................................................................................................................................
Isomethadone ..............................................................................................................................................................................
Meperidine ...................................................................................................................................................................................
Meperidine intermediate-B ...........................................................................................................................................................
Methadone ...................................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ..........................................................................................................................
Morphine ......................................................................................................................................................................................
Thebaine ......................................................................................................................................................................................
Oxymorphone ..............................................................................................................................................................................
Thiafentanil ..................................................................................................................................................................................
Alfentanil ......................................................................................................................................................................................
Remifentanil .................................................................................................................................................................................
Sufentanil .....................................................................................................................................................................................
Carfentanil ....................................................................................................................................................................................
Tapentadol ...................................................................................................................................................................................
Fentanyl .......................................................................................................................................................................................
VerDate Sep<11>2014
16:32 Sep 04, 2020
Jkt 250001
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
E:\FR\FM\08SEN1.SGM
08SEN1
9551
9560
9624
9628
9750
9811
9812
9813
9814
9815
9816
9821
9822
9823
9824
9825
9826
9827
9830
9831
9832
9833
9834
9835
9836
9837
9838
9840
9843
9845
9847
9850
1100
1105
1205
1631
1724
2125
2270
2315
2550
7460
7471
8333
8366
8501
8603
9041
9050
9059
9120
9143
9150
9180
9190
9193
9210
9220
9226
9230
9233
9250
9273
9300
9333
9652
9729
9737
9739
9740
9743
9780
9801
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Federal Register / Vol. 85, No. 174 / Tuesday, September 8, 2020 / Notices
The company plans to bulk
manufacture the listed controlled
substances to produce forensic and
research of analytical reference
standards for distribution to its
customers. In reference to Marihuana
(7360) and Tetrahydrocannabinols
(7370) the company will manufacture as
synthetics only. No other activities for
these drug codes are authorized for this
registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–19805 Filed 9–4–20; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–707]
Importer of Controlled Substances
Application: Aspen API, Inc.
jbell on DSKJLSW7X2PROD with NOTICES
16:32 Sep 04, 2020
Jkt 250001
Remifentanil ..................
Drug
code
9739
Schedule
II
The company plans to import the
listed controlled substance as a bulk
active pharmaceutical ingredient for
distribution to manufacturers of
finished dosage prescription drugs. No
other activity to this drug code is
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
[FR Doc. 2020–19804 Filed 9–4–20; 8:45 am]
BILLING CODE P
Aspen API, Inc. has applied
to be registered as an importer of basic
class(es) of controlled substance. Refer
to Supplemental Information listed
below for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before October 8, 2020. Such persons
may also file a written request for a
hearing on the application on or before
October 8, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on August 3, 2020, Aspen
API, Inc., 2136 South Wolf Road, Des
Plaines, Illinois 60018–1932, applied to
be registered as an importer of the
VerDate Sep<11>2014
Controlled substance
William T. McDermott,
Assistant Administrator.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
SUMMARY:
following basic class(es) of controlled
substance:
DEPARTMENT OF JUSTICE
Notice of Lodging of Proposed
Consent Decree Under the Clean Air
Act
On August 31, 2020, the U. S.
Department of Justice (DOJ) lodged a
proposed Consent Decree with the
United States District Court for the
Southern District of Indiana in United
States and State of Indiana v.
Indianapolis Power & Light Company,
Civil Action No. 3:20–cv–202. The
lodging of the proposed Decree
immediately followed DOJ’s filing in the
same court of a civil complaint
(Complaint) against Indianapolis Power
& Light Company (IPL).
The proposed Consent Decree
resolves Clean Air Act and related State
law claims in the Complaint by the
United States on behalf of the U.S.
Environmental Protection Agency, and
the State of Indiana, by the authority of
the Attorney General of Indiana, acting
at the request of the Indiana Department
of Environmental Management. Under
the proposed Decree, IPL agrees, among
other things, to undertake measures to
reduce pollutant emissions and improve
its environmental compliance at the
Petersburg Generating Station (Facility)
in Pike County, Indiana. In addition, IPL
will pay a civil penalty, perform a
mitigation project proposing a new,
non-emitting source of power to serve
the Facility’s internal load, and conduct
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
55497
a State-only Environmentally Beneficial
Project.
The publication of this notice opens
a period for public comment on the
proposed Consent Decree. Comments
should be addressed to the Assistant
Attorney General, Environment and
Natural Resources Division, and should
refer to United States and State of
Indiana v. Indianapolis Power & Light
Company, D.J. Ref. No. 90–5–2–1–
09897/1. All comments must be
submitted no later than thirty (30) days
after the publication date of this notice.
Comments may be submitted either by
email or by mail:
To submit
comments:
Send them to:
By email .......
pubcomment-ees.enrd@
usdoj.gov.
Assistant Attorney General,
U.S. DOJ—ENRD, P.O.
Box 7611, Washington,
D.C. 20044–7611.
By mail .........
During the public comment period,
the proposed Consent Decree may be
examined and downloaded at this
Justice Department website: https://
www.justice.gov/enrd/consent-decrees.
We will provide a paper copy of the
proposed Consent Decree upon written
request and payment of reproduction
costs. Please mail your request and
payment to: Consent Decree Library,
U.S. DOJ—ENRD, P.O. Box 7611,
Washington, DC 20044–7611.
Please enclose a check or money order
for $19.00 (25 cents per page
reproduction cost), payable to the
United States Treasury.
Jeffrey Sands,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 2020–19691 Filed 9–4–20; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF LABOR
Veterans’ Employment and Training
Service
Advisory Committee on Veterans’
Employment, Training and Employer
Outreach (ACVETEO): Meeting
Veterans’ Employment and
Training Service (VETS), Department of
Labor (DOL).
ACTION: Notice of virtual open meeting.
AGENCY:
This notice sets forth the
schedule and proposed agenda of a
forthcoming meeting of the ACVETEO.
The ACVETEO will discuss the DOL
core programs and services that assist
SUMMARY:
E:\FR\FM\08SEN1.SGM
08SEN1
]]>Agencies
[Federal Register Volume 85, Number 174 (Tuesday, September 8, 2020)]
[Notices]
[Pages 55493-55497]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-19805]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-708]
Bulk Manufacturer of Controlled Substances Application: Cayman
Chemical Company
AGENCY: Drug Enforcement Administration, Justice.
[[Page 55494]]
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Cayman Chemical Company has applied to be registered as a bulk
manufacturer of basic class(es) controlled substances. Refer to
Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before November 9,
2020. Such persons may also file a written request for a hearing on the
application on or before November 9, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on July 17, 2020, Cayman Chemical Company, 1180 East
Ellsworth Road, Ann Arbor, Michigan 48108-2419, applied to be
registered as a bulk manufacturer of the following basic class(es) of
controlled substances:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC); 1-(3- 1233 I
Fluorophenyl)-2-(Methylamino)Propan-1-one)........
Cathinone.......................................... 1235 I
Methcathinone...................................... 1237 I
4-Fluoro-N-methylcathinone (4-FMC); Flephedrone; 1- 1238 I
( 4-Fluorophenyl)-2-(Methylamino)Propan-1-one)....
Pentedrone ([alpha]-methylaminovalerophenone), its 1246 I
optical, positional and geometric isomers, salts
and salts of isomers..............................
Mephedrone (4-Methyl-N-methylcathinone)............ 1248 I
4-Methyl-N-ethylcathinone (4-MEC).................. 1249 I
Naphyrone, its optical, positional and geometric 1258 I
isomers, salts and salts of isomers...............
N-Ethylamphetamine................................. 1475 I
N,N-Dimethylamphetamine............................ 1480 I
Fenethylline....................................... 1503 I
Aminorex........................................... 1585 I
4-Methylaminorex (cis isomer)...................... 1590 I
Gamma Hydroxybutyric Acid.......................... 2010 I
Methaqualone....................................... 2565 I
Mecloqualone....................................... 2572 I
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) 6250 I
SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2- 7008 I
methoxyphenylacetyl) indole)......................
ADB-FUBINACA (n-(1-amino-3,3-dimethyl-1-oxobutan-2- 7010 I
yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide).
5-Flouro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H- 7011 I
indol-3-yl](2,2,3,3-
tetramethylcyclopropyl)methanone..................
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1- 7012 I
(4-fluorobenzyl)-1H-indazole-3-carboxamide).......
FUB-144............................................ 7014 I
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole)............ 7019 I
MDMB-FUBINACA (Methyl 2-(1-4-fluorobenzyl)-1H- 7020 I
indazole-3-carboxamido)-3,3-dimethylbutanoate)....
2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3- 7021 I
methylbutanoate...................................
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1- 7023 I
pentyl-1H-indazole-3-carboxamide).................
THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3- 7024 I
yl](naphthalen-1-yl)methanone.....................
5F-AB-PINACA....................................... 7025 I
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1- 7031 I
(cyclohexylmethyl)-1H-indazole-3-carboxamide......
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2- 7032 I
yl)-1-(cyclohexylmethyl)-1H-indazole-3-
carboxamide)......................................
5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazola-3- 7033 I
carboxamido)-3-methylbutanoate)...................
5F-ADB; 5F-MDMB-PINACA (Methyl 2-(1-(5fluoropentyl)- 7034 I
1H-indazole-3-carboxamido)-3,3dimethylbutanoate)..
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2- 7035 I
yl)-1-pentyl-1H-indazole-3-carboxamide)...........
5F-EDMB-PINACA..................................... 7036 I
5F-MDMB-PICA)...................................... 7041 I
MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1- 7042 I
(cyclohenxylmethyl)-1H-indole-3-carboxamido)-3,3-
dimethylbutanote)-................................
MMB-CHMICA......................................... 7044 I
FUB-AKB48;FUB-APINACA; AKB48 N-(4-Fluorobenzyl).... 7047 I
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H- 7048 I
indazole-3-carboxamide............................
5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-1- 7049 I
(5fluoropentyl)-1H-indazole-3-carboxamide)........
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) 7081 I
5F-CUMYL-PINACA;SGT-25............................. 7083 I
5F-CUMYL-P7AICA.................................... 7085 I
4-CN-CUMYL-BUTINACA................................ 7089 I
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4- 7104 I
methoxy)-benzoyl] indole..........................
JWH-018 (also known as AM678) (1-Pentyl-3-(1- 7118 I
naphthoyl)indole).................................
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole). 7122 I
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- 7144 I
tetramethylcyclopropyl)methanone..................
JWH-073 (1-Butyl-3-(1-naphthoyl)indole)............ 7173 I
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1- 7200 I
naphthoyl)indole).................................
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole). 7201 I
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole). 7203 I
NM2201............................................. 7221 I
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3- 7222 I
carboxylate)......................................
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H- 7225 I
indole-3-carboxylate).............................
4-Methyl-Alpha-Ethylaminopentiophennone............ 7245 I
[[Page 55495]]
N-Ethylhexedrone, its optical, positional and 7246 I
geometric isomers, salts and salts of isomers.....
Alpha-ethyltryptamine.............................. 7249 I
Ibogaine........................................... 7260 I
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3- 7297 I
hydroxycyclohexyl-phenol).........................
CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2- 7298 I
[(1R,3S)3-hydroxycyclohexyl-phenol)...............
Lysergic acid diethylamide......................... 7315 I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T- 7348 I
7)................................................
Marihuana.......................................... 7360 I
Tetrahydrocannabinols.............................. 7370 I
Mescaline.......................................... 7381 I
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C- 7385 I
T-2 ).............................................
3,4,5-Trimethoxyamphetamine........................ 7390 I
4-Bromo-2,5-dimethoxyamphetamine................... 7391 I
4-Bromo-2,5-dimethoxyphenethylamine................ 7392 I
4-Methyl-2,5-dimethoxyamphetamine.................. 7395 I
2,5-Dimethoxyamphetamine........................... 7396 I
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole). 7398 I
2,5-Dimethoxy-4-ethylamphetamine................... 7399 I
3,4-Methylenedioxyamphetamine...................... 7400 I
5-Methoxy-3,4-methylenedioxyamphetamine............ 7401 I
N-Hydroxy-3,4-methylenedioxyamphetamine............ 7402 I
3,4-Methylenedioxy-N-ethylamphetamine.............. 7404 I
3,4-Methylenedioxymethamphetamine.................. 7405 I
4-Methoxyamphetamine............................... 7411 I
5-Methoxy-N-N-dimethyltryptamine................... 7431 I
Alpha-methyltryptamine............................. 7432 I
Bufotenine......................................... 7433 I
Diethyltryptamine.................................. 7434 I
Dimethyltryptamine................................. 7435 I
Psilocybin......................................... 7437 I
Psilocyn........................................... 7438 I
5-Methoxy-N,N-diisopropyltryptamine................ 7439 I
4-CHLORO-ALPHA-Pyrrolidinovalerophenone, its 7443 I
optical, positional and geometric isomers, salts
and salts of isomers..............................
4-METHYL-ALPHA-Pyrrolidinohexiophenone, its 7446 I
optical, positional and geometric isomers, salts
and salts of isomers..............................
N-Ethyl-1-phenylcyclohexylamine.................... 7455 I
1-(1-Phenylcyclohexyl)pyrrolidine.................. 7458 I
1-[1-(2-Thienyl)cyclohexyl]piperidine.............. 7470 I
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine............. 7473 I
N-Benzylpiperazine................................. 7493 I
4-Methyl-Alpha-pyrrolidinopropiophenone, its 7498 I
optical, positional and geometric isomers, salts
and salts of isomers..............................
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D). 7508 I
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E ). 7509 I
2-(2,5-Dimethoxyphenyl) ethanamine (2C-H).......... 7517 I
2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C-I)... 7518 I
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C). 7519 I
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N). 7521 I
2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C- 7524 I
P)................................................
2-[4-(Isopropylthio)-2,5-dimethoxyphenyl] 7532 I
ethanamine (2C-T-4 )..............................
MDPV (3,4-Methylenedioxypyrovalerone).............. 7535 I
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) 7536 I
ethanamine (25B-NBOMe)............................
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2- 7537 I
methoxybenzyl)ethanamine (25C-NBOMe)..............
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) 7538 I
ethanamine (25I-NBOMe)............................
Methylone (3,4-Methylenedioxy-N-methylcathinone)... 7540 I
Butylone, its optical, positional and geometric 7541 I
isomers, salts and salts of isomers...............
Pentylone, its optical, positional and geometric 7542 I
isomers, salts and salts of isomers...............
N-Ethylpentylone, or Ephylone...................... 7543 I
ALPHA-Pyrrolidinohexanophenone..................... 7544 I
alpha-pyrrolidinopentiophenone ([alpha]-PVP), its 7545 I
optical, positional and geometric isomers, salts
and salts of isomers..............................
alpha-pyrrolidinobutiophenone ([alpha]-PBP), its 7546 I
optical, positional and geometric isomers, salts
and salts of isomers..............................
Ethylone........................................... 7547 I
ALPHA-Pyrrolidinoheptaphenone, its optical, 7548 I
positional and geometric isomers, salts and salts
of isomers........................................
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) 7694 I
indole)...........................................
Acetyldihydrocodeine............................... 9051 I
Benzylmorphine..................................... 9052 I
Codeine-N-oxide.................................... 9053 I
Desomorphine....................................... 9055 I
Etorphine (except HCl)............................. 9056 I
Codeine methylbromide.............................. 9070 I
Dihydromorphine.................................... 9145 I
Heroin............................................. 9200 I
Morphine-N-oxide................................... 9307 I
Normorphine........................................ 9313 I
U-47700 (3,4-dichloro-N-[2- 9547 I
(dimethylamino)cyclohexyl]-N-methylbenzamide).....
[[Page 55496]]
AH-7921............................................ 9551 I
MT-45 (1-cyclohexyl-4-(1,2- 9560 I
diphenylethyl)piperazine))........................
Etonitazene........................................ 9624 I
Ketobemidone....................................... 9628 I
Tilidine........................................... 9750 I
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- 9811 I
phenylacrylamide).................................
Para-Fluorofentanyl................................ 9812 I
3-Methylfentanyl................................... 9813 I
Alpha-methylfentanyl............................... 9814 I
Acetyl-alpha-methylfentanyl........................ 9815 I
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4- 9816 I
yl)propionamide...................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N- 9821 I
phenylacetamide)..................................
Butyryl Fentanyl................................... 9822 I
Para-fluorobutyryl fentanyl........................ 9823 I
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N- 9824 I
(1phenethylpiperidin-4-yl)isobutyramide)..........
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N- 9825 I
phenylacetamide...................................
Para-chloroisobutyryl fentanyl..................... 9826 I
Isobutyryl fentanyl................................ 9827 I
Beta-hydroxyfentanyl............................... 9830 I
Beta-hydroxy-3-methylfentanyl...................... 9831 I
Alpha-methylthiofentanyl........................... 9832 I
3-Methylthiofentanyl............................... 9833 I
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- 9834 I
phenylfuran-2-carboxamide)........................
Thiofentanyl....................................... 9835 I
Beta-hydroxythiofentanyl........................... 9836 I
Para-methoxybutyryl fentanyl....................... 9837 I
Ocfentanil......................................... 9838 I
Valeryl fentanyl................................... 9840 I
N-(1-phenethylpiperidin-4-yl)-N- 9843 I
phenyltetrahydrofuran-2-carboxamide...............
Cyclopropyl Fentanyl............................... 9845 I
Cyclopentyl fentanyl............................... 9847 I
Fentanyl related-compounds as defined in 21 CFR 9850 I
1308.11(h)........................................
Amphetamine........................................ 1100 II
Methamphetamine.................................... 1105 II
Lisdexamfetamine................................... 1205 II
Phenmetrazine...................................... 1631 II
Methylphenidate.................................... 1724 II
Amobarbital........................................ 2125 II
Pentobarbital...................................... 2270 II
Secobarbital....................................... 2315 II
Glutethimide....................................... 2550 II
1-Phenylcyclohexylamine............................ 7460 II
Phencyclidine...................................... 7471 II
4-Anilino-N-phenethyl-4-piperidine (ANPP).......... 8333 II
Norfentanyl........................................ 8366 II
Phenylacetone...................................... 8501 II
1-Piperidinocyclohexanecarbonitrile................ 8603 II
Cocaine............................................ 9041 II
Codeine............................................ 9050 II
Etorphine HCl...................................... 9059 II
Dihydrocodeine..................................... 9120 II
Oxycodone.......................................... 9143 II
Hydromorphone...................................... 9150 II
Ecgonine........................................... 9180 II
Ethylmorphine...................................... 9190 II
Hydrocodone........................................ 9193 II
Levomethorphan..................................... 9210 II
Levorphanol........................................ 9220 II
Isomethadone....................................... 9226 II
Meperidine......................................... 9230 II
Meperidine intermediate-B.......................... 9233 II
Methadone.......................................... 9250 II
Dextropropoxyphene, bulk (non-dosage forms)........ 9273 II
Morphine........................................... 9300 II
Thebaine........................................... 9333 II
Oxymorphone........................................ 9652 II
Thiafentanil....................................... 9729 II
Alfentanil......................................... 9737 II
Remifentanil....................................... 9739 II
Sufentanil......................................... 9740 II
Carfentanil........................................ 9743 II
Tapentadol......................................... 9780 II
Fentanyl........................................... 9801 II
------------------------------------------------------------------------
[[Page 55497]]
The company plans to bulk manufacture the listed controlled
substances to produce forensic and research of analytical reference
standards for distribution to its customers. In reference to Marihuana
(7360) and Tetrahydrocannabinols (7370) the company will manufacture as
synthetics only. No other activities for these drug codes are
authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-19805 Filed 9-4-20; 8:45 am]
BILLING CODE 4410-09-P
